A citation-based method for searching scientific literature

N Dubey, J F Hoffman, K Schuebel, Q Yuan, P E Martinez, L K Nieman, D R Rubinow, P J Schmidt, D Goldman. Mol Psychiatry 2017
Times Cited: 32







List of co-cited articles
250 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome.
P J Schmidt, L K Nieman, M A Danaceau, L F Adams, D R Rubinow. N Engl J Med 1998
439
53

Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels.
Peter J Schmidt, Pedro E Martinez, Lynnette K Nieman, Deloris E Koziol, Karla D Thompson, Linda Schenkel, Paul G Wakim, David R Rubinow. Am J Psychiatry 2017
53
37

5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
Pedro E Martinez, David R Rubinow, Lynnette K Nieman, Deloris E Koziol, A Leslie Morrow, Crystal E Schiller, Dahima Cintron, Karla D Thompson, Khursheed K Khine, Peter J Schmidt. Neuropsychopharmacology 2016
55
31


Abnormalities of dorsolateral prefrontal function in women with premenstrual dysphoric disorder: a multimodal neuroimaging study.
Erica B Baller, Shau-Ming Wei, Philip D Kohn, David R Rubinow, Gabriela Alarcón, Peter J Schmidt, Karen F Berman. Am J Psychiatry 2013
49
25

Reproductive Steroid Regulation of Mood and Behavior.
Crystal Edler Schiller, Sarah L Johnson, Anna C Abate, Peter J Schmidt, David R Rubinow. Compr Physiol 2016
66
21

The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD).
Uriel Halbreich, Jeff Borenstein, Terry Pearlstein, Linda S Kahn. Psychoneuroendocrinology 2003
258
21

Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression: A Randomized Clinical Trial.
Peter J Schmidt, Rivka Ben Dor, Pedro E Martinez, Gioia M Guerrieri, Veronica L Harsh, Karla Thompson, Deloris E Koziol, Lynnette K Nieman, David R Rubinow. JAMA Psychiatry 2015
93
18

Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene.
Liang Huo, Richard E Straub, Catherine Roca, Peter J Schmidt, Kai Shi, Radhakrishna Vakkalanka, Daniel R Weinberger, David R Rubinow. Biol Psychiatry 2007
83
18

The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: a meta analysis.
Katrina M Wyatt, Paul W Dimmock, Khaled M K Ismail, Peter W Jones, P M Shaughn O'Brien. BJOG 2004
79
15

Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)-A randomized controlled trial.
Marie Bixo, Karin Ekberg, Inger Sundström Poromaa, Angelica Lindén Hirschberg, Aino Fianu Jonasson, Lotta Andréen, Erika Timby, Marianne Wulff, Agneta Ehrenborg, Torbjörn Bäckström. Psychoneuroendocrinology 2017
43
15

Daily Record of Severity of Problems (DRSP): reliability and validity.
J Endicott, J Nee, W Harrison. Arch Womens Ment Health 2006
207
15

Premenstrual dysphoric disorder: evidence for a new category for DSM-5.
C Neill Epperson, Meir Steiner, S Ann Hartlage, Elias Eriksson, Peter J Schmidt, Ian Jones, Kimberly A Yonkers. Am J Psychiatry 2012
132
15

Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: a systematic review.
Simone Toffoletto, Rupert Lanzenberger, Malin Gingnell, Inger Sundström-Poromaa, Erika Comasco. Psychoneuroendocrinology 2014
141
15

The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: effects of estradiol and progesterone addback.
T V Nguyen, J M Reuter, N W Gaikwad, D M Rotroff, H R Kucera, A Motsinger-Reif, C P Smith, L K Nieman, D R Rubinow, R Kaddurah-Daouk,[...]. Transl Psychiatry 2017
11
45

Lack of effect of induced menses on symptoms in women with premenstrual syndrome.
P J Schmidt, L K Nieman, G N Grover, K L Muller, G R Merriam, D R Rubinow. N Engl J Med 1991
125
15

Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles.
Lee S Cohen, Claudio N Soares, Michael W Otto, Bernadette H Sweeney, Rebecca F Liberman, Bernard L Harlow. J Affect Disord 2002
112
15

The premenstrual symptoms screening tool (PSST) for clinicians.
M Steiner, M Macdougall, E Brown. Arch Womens Ment Health 2003
192
12

Premenstrual Dysphoric Disorder: Epidemiology and Treatment.
Liisa Hantsoo, C Neill Epperson. Curr Psychiatry Rep 2015
69
12

Sex-specific transcriptional signatures in human depression.
Benoit Labonté, Olivia Engmann, Immanuel Purushothaman, Caroline Menard, Junshi Wang, Chunfeng Tan, Joseph R Scarpa, Gregory Moy, Yong-Hwee E Loh, Michael Cahill,[...]. Nat Med 2017
258
12

Rapid estrogen signaling in the brain: implications for the fine-tuning of neuronal circuitry.
Deepak P Srivastava, Elizabeth M Waters, Paul G Mermelstein, Enikö A Kramár, Tracey J Shors, Feng Liu. J Neurosci 2011
92
12

Effects of gonadal steroids in women with a history of postpartum depression.
M Bloch, P J Schmidt, M Danaceau, J Murphy, L Nieman, D R Rubinow. Am J Psychiatry 2000
491
12

Prevalence, incidence and stability of premenstrual dysphoric disorder in the community.
H -U Wittchen, E Becker, R Lieb, P Krause. Psychol Med 2002
302
12

Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials.
Samantha Meltzer-Brody, Helen Colquhoun, Robert Riesenberg, C Neill Epperson, Kristina M Deligiannidis, David R Rubinow, Haihong Li, Abdul J Sankoh, Christine Clemson, Amy Schacterle,[...]. Lancet 2018
174
12

Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS).
Tory A Eisenlohr-Moul, Susan S Girdler, Katja M Schmalenberger, Danyelle N Dawson, Pallavi Surana, Jacqueline L Johnson, David R Rubinow. Am J Psychiatry 2017
30
13

Selective serotonin reuptake inhibitors for premenstrual syndrome.
Jane Marjoribanks, Julie Brown, Patrick Michael Shaughn O'Brien, Katrina Wyatt. Cochrane Database Syst Rev 2013
85
12

Premenstrual dysphoric disorder and prefrontal reactivity during anticipation of emotional stimuli.
Malin Gingnell, Elin Bannbers, Johan Wikström, Mats Fredrikson, Inger Sundström-Poromaa. Eur Neuropsychopharmacol 2013
31
12

Emotional fronto-cingulate cortex activation and brain derived neurotrophic factor polymorphism in premenstrual dysphoric disorder.
Erika Comasco, Andreas Hahn, Sebastian Ganger, Malin Gingnell, Elin Bannbers, Lars Oreland, Johan Wikström, C Neill Epperson, Rupert Lanzenberger, Inger Sundström-Poromaa. Hum Brain Mapp 2014
29
13

Risk factors for premenstrual dysphoric disorder in a community sample of young women: the role of traumatic events and posttraumatic stress disorder.
Axel Perkonigg, Kimberly A Yonkers, Hildegard Pfister, Roselind Lieb, Hans-Ulrich Wittchen. J Clin Psychiatry 2004
77
12

Histories of abuse predict stronger within-person covariation of ovarian steroids and mood symptoms in women with menstrually related mood disorder.
Tory A Eisenlohr-Moul, David R Rubinow, Crystal E Schiller, Jacqueline L Johnson, Jane Leserman, Susan S Girdler. Psychoneuroendocrinology 2016
22
18

Emotion regulation in women with premenstrual dysphoric disorder.
Nicole Petersen, Edythe D London, Letty Liang, Dara G Ghahremani, Rachel Gerards, Linda Goldman, Andrea J Rapkin. Arch Womens Ment Health 2016
23
17

Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
C Neill Epperson, Kristin Haga, Graeme F Mason, Edward Sellers, Ralitza Gueorguieva, Wenjiang Zhang, Erica Weiss, Douglas L Rothman, John H Krystal. Arch Gen Psychiatry 2002
239
12

Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs.
Meir Steiner, Teri Pearlstein, Lee S Cohen, Jean Endicott, Susan G Kornstein, Carla Roberts, David L Roberts, Kimberly Yonkers. J Womens Health (Larchmt) 2006
75
9

Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness.
Andrea J Rapkin, Sharon A Winer. Expert Rev Pharmacoecon Outcomes Res 2009
81
9

Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons.
T Bäckström, D Haage, M Löfgren, I M Johansson, J Strömberg, S Nyberg, L Andréen, L Ossewaarde, G A van Wingen, S Turkmen,[...]. Neuroscience 2011
77
9

Addressing concerns about the inclusion of premenstrual dysphoric disorder in DSM-5.
S Ann Hartlage, Cynthia A Breaux, Kimberly A Yonkers. J Clin Psychiatry 2014
19
15

Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.
Kimberly A Yonkers, Candace Brown, Teri B Pearlstein, Marie Foegh, Carole Sampson-Landers, Andrea Rapkin. Obstet Gynecol 2005
189
9

Hormonal gain control of a medial preoptic area social reward circuit.
Jenna A McHenry, James M Otis, Mark A Rossi, J Elliott Robinson, Oksana Kosyk, Noah W Miller, Zoe A McElligott, Evgeny A Budygin, David R Rubinow, Garret D Stuber. Nat Neurosci 2017
121
9

Gonadal hormone modulation of intracellular calcium as a mechanism of neuroprotection.
Susan L Zup, Amanda M K Madden. Front Neuroendocrinol 2016
6
50

Estrogen promotes stress sensitivity in a prefrontal cortex-amygdala pathway.
Rebecca M Shansky, Carine Hamo, Patrick R Hof, Wendy Lou, Bruce S McEwen, John H Morrison. Cereb Cortex 2010
123
9


Sex Differences in Nucleus Accumbens Transcriptome Profiles Associated with Susceptibility versus Resilience to Subchronic Variable Stress.
Georgia E Hodes, Madeline L Pfau, Immanuel Purushothaman, H Francisca Ahn, Sam A Golden, Daniel J Christoffel, Jane Magida, Anna Brancato, Aki Takahashi, Meghan E Flanigan,[...]. J Neurosci 2015
186
9

Estrogen-serotonin interactions: implications for affective regulation.
D R Rubinow, P J Schmidt, C A Roca. Biol Psychiatry 1998
346
9

Sex differences in the structural connectome of the human brain.
Madhura Ingalhalikar, Alex Smith, Drew Parker, Theodore D Satterthwaite, Mark A Elliott, Kosha Ruparel, Hakon Hakonarson, Raquel E Gur, Ruben C Gur, Ragini Verma. Proc Natl Acad Sci U S A 2014
468
9

Direct binding of estradiol enhances Slack (sequence like a calcium-activated potassium channel) channels' activity.
L Zhang, M Sukhareva, J L Barker, D Maric, Y Hao, Y H Chang, W Ma, T O'Shaughnessy, D R Rubinow. Neuroscience 2005
17
17

Neural Activation in Women in Response to Masculinized Male Faces: Mediation by Hormones and Psychosexual Factors.
Heather A Rupp, Thomas W James, Ellen D Ketterson, Dale R Sengelaub, Erick Janssen, Julia R Heiman. Evol Hum Behav 2009
34
9

Sex-related differences in MAPKs activation in rat astrocytes: effects of estrogen on cell death.
Lei Zhang, Beng shing Li, Weqing Zhao, Yoong H Chang, Wu Ma, M Dragan, Jeffery L Barker, Qian Hu, David R Rubinow. Brain Res Mol Brain Res 2002
53
9

Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women.
K F Berman, P J Schmidt, D R Rubinow, M A Danaceau, J D Van Horn, G Esposito, J L Ostrem, D R Weinberger. Proc Natl Acad Sci U S A 1997
239
9


Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor.
M D Majewska, N L Harrison, R D Schwartz, J L Barker, S M Paul. Science 1986
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.